@inbook{d7a2c556373140ddbda8573bd8f19e93,
title = "Harnessing nanobodies for target protein degradation through the Affinity-directed PROtein Missile (AdPROM) system",
abstract = "Targeted protein degradation (TPD) is a useful approach in dissecting protein function and therapeutics. Technologies such as RNA interference or gene knockout that are routinely used rely on protein turnover. However, RNA interference takes a long time to deplete target proteins and is not suitable for long-lived proteins, while a genetic knockout is irreversible, takes a long time to achieve and is not suitable for essential genes. TPD has the potential to overcome the limitations of RNA interference and gene editing approaches. We have established the Affinity directed PROtein Missile (AdPROM) system, which harnesses nanobodies or binders of target proteins to redirect E3 ubiquitin ligase activity to the target protein to induce TPD through the ubiquitin proteasome system. Here we provide a step-by-step protocol for using the AdPROM system for targeted proteolysis of endogenously GFP-tagged K-RAS through an anti-GFP nanobody. This protocol can be amended to target a wide range of different proteins of interest (POIs) either by replacing the anti-GFP nanobody with a nanobody recognising the POI or by endogenously tagging the POI with GFP through CRISPR/Cas9 genome editing.",
keywords = "AdPROM, E3, Proteasome, Target protein degradation, TPD, Ubiquitin, Ubiquitination",
author = "Bill Carton and Sascha R{\"o}th and Macartney, {Thomas J.} and Sapkota, {Gopal P.}",
note = "Funding Information: This study was funded by the UK Medical Research Council (MRC), awarded to GPS (MC_UU_00018/6). GPS is also supported by the pharmaceutical companies supporting the Division of Signal Transduction Therapy (Boehringer-Ingelheim, GlaxoSmithKline, Merck-Serono). B.C. is funded by a Cunningham Trust PhD studentship. S.R. is currently an employee of AstraZeneca. Copyright: {\textcopyright} 2022 Elsevier Inc. All rights reserved.",
year = "2023",
doi = "10.1016/bs.mie.2022.08.011",
language = "English",
isbn = "9780323992008",
volume = "681",
series = "Methods in Enzymology",
publisher = "Academic Press Inc.",
pages = "61--79",
editor = "Burslem, {George L.}",
booktitle = "Targeted Protein Degradation",
address = "United States",
}